Recruiting A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations NCT05983159 Conditions Arteriovenous Malformation (AVM), Arteriovenous Malformations, Cardiovascular Abnormalities, +30 more Locations Peter MacCallum Cancer Centre — Parkville, Victoria, Australia The Royal Children's Hospital — Parkville, Victoria, Australia View Trial Details
Completed National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS) NCT05563831 Conditions Angiomatosis, CLOVES Syndrome, Cardiovascular Abnormalities, +32 more Locations Translational medicine and Targeted therapies unit, Hôpital Necker Enfants Malades — Paris, France View Trial Details
Completed A Study of the Epidemiology and Hospital Management of Patients With PROS in France NCT07222423 Conditions Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +9 more Locations Novartis — East Hanover, New Jersey, United States View Trial Details
Completed Health-related Quality of Life, Symptom Severity, and Pain Among Patients With PIK3CA-related Overgrowth Spectrum: A Mixed-methods Observational Study NCT05294289 Conditions PIK3CA-related Overgrowth Spectrum Locations Novartis Investigative Site — East Hanover, New Jersey, United States View Trial Details
